Kelsey, Kirkpatrick Named 2021 ASTRO Fellows
By: Sarah Brady, Comms Strategist, Dept. of Radiation Oncology
Honor recognizes exceptional service to the field of radiation oncology and cancer care
The American Society for Radiation Oncology (ASTRO), the world’s largest society for radiation oncology professionals, recently voted to confer upon both Christopher Kelsey, MD, and John Kirkpatrick, MD, PhD, the designation of FASTRO (American Society for Radiation Oncology Fellow). Kelsey and Kirkpatrick will receive their FASTRO designations during ASTRO’s 63rd Annual Meeting to be held Oct. 24 to 27 in Chicago.
Just 28 physicians and medical physicists were designated FASTRO in 2021.
Awarded annually since 2006, the ASTRO Fellows program recognizes individuals who have made significant contributions to radiation oncology through research, education, patient care and/or service to the field. Since its inception, the FASTRO designation has been awarded to just 394 of ASTRO’s more than 10,000 members worldwide.
More information about the Fellows program is available via the ASTRO website, including the complete list of all ASTRO Fellows.
Kelsey and Kirkpatrick are Duke Radiation Oncology's twelfth and thirteenth ASTRO Fellows.
